Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy
Junwei Yang, Ryan W. Shultz, Wendy M. Mars, Rodney E. Wegner, Yingjian Li, Chunsun Dai, Kari Nejak, Youhua Liu
Junwei Yang, Ryan W. Shultz, Wendy M. Mars, Rodney E. Wegner, Yingjian Li, Chunsun Dai, Kari Nejak, Youhua Liu
View: Text | PDF
Article Nephrology

Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy

  • Text
  • PDF
Abstract

Research Article

Authors

Junwei Yang, Ryan W. Shultz, Wendy M. Mars, Rodney E. Wegner, Yingjian Li, Chunsun Dai, Kari Nejak, Youhua Liu

×

Figure 4

Options: View larger image (or click on image) Download as PowerPoint
Reduced α-SMA induction occurs at day 7, but not day 3, after UUO in mic...
Reduced α-SMA induction occurs at day 7, but not day 3, after UUO in mice lacking tPA. (a) Western blot shows α-SMA expression in the obstructed kidney at day 7 after ureteral obstruction in tPA+/+ and tPA–/– mice. The samples were reprobed with actin to confirm equal loading of each lane. Lanes 1–5 represent individual animals in each group. (b) Graphic presentation of relative α-SMA abundance normalized to actin in tPA+/+ and tPA–/– mice. **P < 0.05, n = 5. (c) Representative Western blot shows the time course of α-SMA expression in the obstructed kidneys in tPA+/+ and tPA–/– mice. Sham-operated and obstructed kidneys were collected at 3 days and 7 days after surgery. The kidney homogenates were probed with antibodies against α-SMA and actin, respectively. (d) Graphic presentation of relative α-SMA abundance (fold induction with levels in sham kidney as 1.0) normalized to actin in tPA+/+ and tPA–/– mice at different timepoints (n = 5). *P < 0.01, tPA+/+ vs. tPA–/– mice at day 7 after UUO; †P < 0.05, day 7 vs. day 3 after UUO in tPA–/– mice.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts